Breaking News

Inside Apple's plans to change healthcare

Not rendering correctly? View this email as a web page here.
JSF Horizontal Banner

Digital transformation: Reimagining clinical trial management [Sponsored]

By Joel Berg Tuesday, August 2, 2022 7:30 AM

Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there's a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.

Read more »

With 'bold experiment' in drug pricing, Arcutis aims to stand out in plaque psoriasis

By Frank Vinluan Monday, August 1, 2022 8:10 PM

The FDA approved Arcutis Biotherapeutics drug Zoryve, a topical treatment for plaque psoriasis. With the decision, the company will proceed with a pricing strategy it believes will speed up insurance coverage and patient adoption of the new treatment for the chronic inflammatory skin disorder.

Read more »

Carrot Health founder launches SPV-only health tech VC fund

By Katie Adams Monday, August 1, 2022 6:34 PM

Engage Venture Partners, a Minneapolis-based venture capital firm, recently launched with a focus on early stage medical tech companies. The firm was established to decrease friction between early stage medical tech companies and their investors by bringing its investments to market via special purpose vehicles (SPVs).

Read more »

Coverage delays exacerbate inequity for Medicare beneficiaries

By Patrick Hope Monday, August 1, 2022 2:00 PM

Without reimbursement policies that can meet the opportunity of this new innovative era, patients and their providers will be denied access to the most cutting-edge, care. 

Read more »

FDA hits pause on Beam Therapeutics' off-the-shelf cell therapy for blood cancers

By Frank Vinluan Monday, August 1, 2022 1:26 PM

Beam Therapeutics' application to begin human testing of a cell therapy made with base-editing technology is now under an FDA clinical hold. In other clinical hold news, the FDA lifted a hold on a Celyad Oncology cell therapy clinical trial that was halted in March.

Read more »

BioMEMS founder shares his vision for changing how diagnostics are developed, deployed and administered

By Stephanie Baum Monday, August 1, 2022 9:05 AM

Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions.

Read more »

CDS Hooks: The "so what" of FHIR for clinicians

By Dr. Lucienne Marie Ide Monday, August 1, 2022 9:00 AM

Adding CDS Hooks — the HL7 published specification for clinical decision support — to the technology mix will streamline clinical workflows, particularly as the sources and quantities of data continue to expand at a rapid pace.

Read more »

   

No comments